机译:Adverse Events of Immune Checkpoint Inhibitors Therapy for Urologic Cancer Patients in Clinical Trials: A Collaborative Systematic Review and Meta-analysis
Department of Urology Changhai Hospital Naval Medical University;
Department of Health Statistics Naval Medical University;
Department of Urology Jinling Hospital Clinical School of Medical College Nanjing UniversityDepartment of Radiology Changhai Hospital Naval Medical UniversityDepartment of Urology Valencian Oncology Institute Foundation FIVODepartment of Urology Aldo Moro UniversityDivision of Urology VCU Health SystemDepartment of Urologic Sciences The University of British ColumbiaDivision of Hematology Oncology and Palliative Care Department of Internal Medicine VCU MasseyOncology Unit Andrea Tortora Hospital ASL SalernoDepartment of Urology San Luigi Gonzaga Hospital University of TurinDepartment of Clinical and Experimental Medicine University of Florence. Unit of OncologicGenitourinary Medical Oncology IRCCS San Raffaele Hospital and Scientific InstituteDepartment of Urology GRC n°5 Predictive Onco-Uro AP-HP H?pital Pitié-Salpêtrière SorbonneDepartment of Urology University of Washington Seattle Cancer Care Alliance;
Adverse events; Bladder; Immune checkpoint inhibitors; Immunotherapy; Prostate cancer; Renal cell carcinoma; Renal pelvis; Trials; Ureter; Urology; Urothelial carcinoma;